Clinical Trial Update: A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects [NA]

View source ↗

Summary

An InSightec-sponsored feasibility safety study for benign centrally-located intracranial tumors in pediatric and young adult subjects is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Centrally-located Intracranial Tumors

Snippet

Sponsor: InSightec | Conditions: Benign Centrally-Located Intracranial Tumors | NA | Status: RECRUITING